CASE STUDY

Antibody-Drug Conjugates

Meet your method development and sample testing needs for payloads and biologics for all phases of drug development.

Access our 20+ years of ADC experience, including preclinical through FDA approval of LC/MS and LBA assays for payloads and biologics.

When a complex ADA assay failed at two prior CROs, the sponsor turned to BioAgilytix for help. See how we applied a novel approach to overcome target interference challenges on a tight deadline.

What You'll Learn:
  • How BioAgilytix conducted the GCP study evaluating the drug for multiple indications.
  • An in-depth overview of the innovative solution BioAgilytix created to overcome target interference challenges caused by dimerization.
  • How the assay got back on track, and how this same solution can be applied to other studies, such as oncological programs.
Modality_LM_ADCs_2_300x200

Share this Resource

icon-twitter icon-linkedin link 1

Services

Ready-to-go Methods Save Time and Money

  • Support for rapid LC/MS method development and sample testing leveraging our broad small molecule experience
  • Begin sample testing quickly for your PK and ADA assays leveraging our immunogenicity (cell-based NAb) assay experience 
Trust a Team of Scientific Experts to Deliver Cohesive, High-quality Bioanalytical Results
  • Benefit from working with a single team that drives both the assay development and sample testing
  • Work with Project Managers who directly coordinate all your critical assay work, ensuring on-time deliverables according to your priorities and requirements
Optimal Platforms for ADC Development
  • Sciex Triple Quad™ 7500 LC-MS/MS with Exion 2.0+ UHPLC
  • Sciex ZenoTOF 7600 with Sciex ECHO®MS+ or Waters ACQUITY Premier UPLC®
  • Thermo Scientific Orbitrap Exploris 240 with Vanquish Flex UHPLC
  • Waters Xevo TQ-S LC-MS/MS System with Acquity UPLC

 

Share this Resource

icon-twitter icon-linkedin link 1

Our ADC Services Include

Pharmacokinetics 

Rely on a team of experienced scientists to develop PK assays and generate reproducible and reliable results to support your drug program. 

Immunogenicity

Optimize drug safety with industry-leading immunogenicity and testing expertise to advance your program.

Biomarkers

Improve clinical trial efficacy and safety with comprehensive, fit-for-purpose biomarker analysis for your program.

Ready to Start Your Project?

Our scientists are available to discuss your ADC project and how our bioanalytical CRO can help you streamline the drug development process.